[Immunosuppressive therapy in systemic lupus erythematosus].
D000974:Antibodies, Antinuclear; D001323:Autoantibodies; D001379:Azathioprine / Q000627:therapeutic use*; D002648:Child; D003095:Collagen Diseases / Q000188:drug therapy; D003520:Cyclophosphamide / Q000627:therapeutic use*; D005069:Evaluation Studies as Topic; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use*; D007165:Immunosuppression Therapy; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy* / Q000276:immunology; D015122:Mercaptopurine / Q000627:therapeutic use*; D011241:Prednisone / Q000627:therapeutic use*; D011344:Procarbazine / Q000627:therapeutic use
D000974:Antibodies, Antinuclear; D001323:Autoantibodies; D006834:Hydrazines; D011344:Procarbazine; D003520:Cyclophosphamide; D015122:Mercaptopurine; D001379:Azathioprine; D011241:Prednisone
Immunsuppressive Therapie bei Lupus erythematodes visceralis.